296 related articles for article (PubMed ID: 23414411)
1. Virus-like particles produced in plants as potential vaccines.
Scotti N; Rybicki EP
Expert Rev Vaccines; 2013 Feb; 12(2):211-24. PubMed ID: 23414411
[TBL] [Abstract][Full Text] [Related]
2. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
3. Recent advancements in combination subunit vaccine development.
Tan M; Jiang X
Hum Vaccin Immunother; 2017 Jan; 13(1):180-185. PubMed ID: 27649319
[TBL] [Abstract][Full Text] [Related]
4. Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice.
Zhao H; Li HY; Han JF; Deng YQ; Li YX; Zhu SY; He YL; Qin ED; Chen R; Qin CF
Appl Microbiol Biotechnol; 2013 Dec; 97(24):10445-52. PubMed ID: 24085395
[TBL] [Abstract][Full Text] [Related]
5. Plant-based vaccines against viruses.
Rybicki EP
Virol J; 2014 Dec; 11():205. PubMed ID: 25465382
[TBL] [Abstract][Full Text] [Related]
6. The application of virus-like particles to human diseases.
Buonaguro F; Buonaguro L
Expert Rev Vaccines; 2013 Feb; 12(2):99. PubMed ID: 23414399
[No Abstract] [Full Text] [Related]
7. Plant-based vaccines: novel and low-cost possible route for Mediterranean innovative vaccination strategies.
Aboul-Ata AA; Vitti A; Nuzzaci M; El-Attar AK; Piazzolla G; Tortorella C; Harandi AM; Olson O; Wright SA; Piazzolla P
Adv Virus Res; 2014; 89():1-37. PubMed ID: 24751193
[TBL] [Abstract][Full Text] [Related]
8. Plant-derived virus-like particles as vaccines.
Chen Q; Lai H
Hum Vaccin Immunother; 2013 Jan; 9(1):26-49. PubMed ID: 22995837
[TBL] [Abstract][Full Text] [Related]
9. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum.
Kohl TO; Hitzeroth II; Christensen ND; Rybicki EP
BMC Biotechnol; 2007 Sep; 7():56. PubMed ID: 17850660
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus vaccines in plants.
Giorgi C; Franconi R; Rybicki EP
Expert Rev Vaccines; 2010 Aug; 9(8):913-24. PubMed ID: 20673013
[TBL] [Abstract][Full Text] [Related]
11. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
Arora U; Tyagi P; Swaminathan S; Khanna N
Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
[TBL] [Abstract][Full Text] [Related]
12. Current status of plant-made vaccines for veterinary purposes.
Ling HY; Pelosi A; Walmsley AM
Expert Rev Vaccines; 2010 Aug; 9(8):971-82. PubMed ID: 20673018
[TBL] [Abstract][Full Text] [Related]
13. His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface display.
Koho T; Ihalainen TO; Stark M; Uusi-Kerttula H; Wieneke R; Rahikainen R; Blazevic V; Marjomäki V; Tampé R; Kulomaa MS; Hytönen VP
Eur J Pharm Biopharm; 2015 Oct; 96():22-31. PubMed ID: 26170162
[TBL] [Abstract][Full Text] [Related]
14. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic.
López-Macías C
Hum Vaccin Immunother; 2012 Mar; 8(3):411-4. PubMed ID: 22330956
[TBL] [Abstract][Full Text] [Related]
15. Epitope engineering and molecular metrics of immunogenicity: a computational approach to VLP-based vaccine design.
Joshi H; Lewis K; Singharoy A; Ortoleva PJ
Vaccine; 2013 Oct; 31(42):4841-7. PubMed ID: 23933338
[TBL] [Abstract][Full Text] [Related]
16. Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein.
Wang W; Chen X; Xue C; Du Y; Lv L; Liu Q; Li X; Ma Y; Shen H; Cao Y
Vaccine; 2012 Nov; 30(49):7072-7. PubMed ID: 23036496
[TBL] [Abstract][Full Text] [Related]
17. Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines.
Salazar-González JA; Angulo C; Rosales-Mendoza S
Vaccine; 2015 Jul; 33(31):3650-8. PubMed ID: 26073010
[TBL] [Abstract][Full Text] [Related]
18. Efficient production of Japanese encephalitis virus-like particles by recombinant lepidopteran insect cells.
Yamaji H; Nakamura M; Kuwahara M; Takahashi Y; Katsuda T; Konishi E
Appl Microbiol Biotechnol; 2013 Feb; 97(3):1071-9. PubMed ID: 22948954
[TBL] [Abstract][Full Text] [Related]
19. Plant-based vaccines against human hepatitis B virus.
Shchelkunov SN; Shchelkunova GA
Expert Rev Vaccines; 2010 Aug; 9(8):947-55. PubMed ID: 20673016
[TBL] [Abstract][Full Text] [Related]
20. Recombinant vaccines.
Barnard RT
Expert Rev Vaccines; 2010 May; 9(5):461-3. PubMed ID: 20450319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
